Overview

A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential

Status:
Completed
Trial end date:
2019-05-30
Target enrollment:
Participant gender:
Summary
This is a two-part study to determine the relative bioavailability of two different prototype capsules of GDC-0134 to that of an existing reference capsule of GDC-0134 under both fed and fasted conditions. The study is open to healthy female participants of non-childbearing potential.
Phase:
Phase 1
Details
Lead Sponsor:
Genentech, Inc.